HFpEF - Heart Failure With Preserved Ejection Fraction
28
13
14
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 28 trials
100.0%
+13.5% vs benchmark
11%
3 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (28)
Finerenone in Patients Undergoing Transcatheter Aortic Valve Implantation With Heart Failure
CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation
Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction
Testing the CHAT Program for Patients With Heart Failure
Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)
Can Tiny Bubbles Offer an Alternative to Catheters for Assessing Pressures Inside the Heart? Investigating Ultrasound Contrast Agents as Pressure Sensors Against Gold Standard Catheter Pressures in Cardiac Catheterisation Patients.
Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data
Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction
Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension
HEART Camp Connect -Promoting Exercise in Adults With Heart Failure With Preserved Ejection Fraction
AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure
Tailored Exercise Training Study Among Adults With HFpEF
US Benchmarking Clinical Study
MOVE-HF MOtivating Physical Activity With BehaVioral Economics in Heart Failure With Preserved Ejection Fraction
The Safety and Efficacy of Pulsed Field Ablation for Patients With Persistent Atrial Fibrillation Comorbid With HFpEF.
IMPROVE-DiCE: Study to Evaluate Effect of IMB-1018972 on Cardiac Energetics in T2DM & Obesity (Pt 1) With HFpEF (Pt 2)
Serum IGF1 on Female HFpEF Patients
Heart Failure in Patients With Diabetes: Cells, Crosstalk and Consequences
Role of Colchicine as Anti-Inflammatory Therapy in HFpEF
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor